JSC Group of companies Medsi

Moscow 125284

0 studies enrolling now · 2 studies all time

What they study most

HER2 Exon 20 Mutation, Neoplasms, Non-squamous NSCLC, Non-squamous, Non-Small-Cell Lung Cancer

Studies at this site

• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours — Completed